Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE